The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
||||||||||||||||
| COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
| VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
| NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
| APOLLO ENDOSURGERY INC | COM | 03767D108 | 32,698 | 3,878,742 | SH | SOLE | 3,878,742 | 0 | 0 | ||
| INSTIL BIO INC | COM | 45783C101 | 145,072 | 8,478,790 | SH | SOLE | 8,478,790 | 0 | 0 | ||
| INVESCO QQQ TR | UNIT SER 1 | 46090E103 | 7,441 | 18,704 | SH | SOLE | 18,704 | 0 | 0 | ||
| PROCEPT BIOROBOTICS CORP | COM | 74276L105 | 280,679 | 11,222,662 | SH | SOLE | 11,222,662 | 0 | 0 | ||
| REATA PHARMACEUTICALS INC | CL A | 75615P103 | 76,391 | 2,896,901 | SH | SOLE | 2,896,901 | 0 | 0 | ||